Loading...
Fremanezumab in Children and Adolescents with Episodic Migraine | NEJM Clinician
NEJM Research Summary
Fremanezumab in Children and Adolescents with Episodic Migraine
New England Journal of Medicine
Feb 5
New England Journal of Medicine
February 5
New England Journal of Medicine
February 5
Related Content
Journal Watch
A Monoclonal Antibody to Prevent Migraine in Children and Adolescents
Original Article
Fremanezumab in Children and Adolescents with Episodic Migraine
Topics
Neurology/Neurosurgery
Pain
Pediatrics
Pediatrics General